New Science Ventures Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
6
- Investments
-
119
- Portfolio
-
33
- Exits
-
43
New Science Ventures General Information
Description
Founded in 2004, New Science Ventures is a venture capital firm based in Greenwich, Connecticut. The firm seeks to invest in pharmaceuticals, biotechnology, healthcare devices, healthcare technology systems, consumer durables, life sciences, health tech, information technology, and digital health sectors in the United States, Europe.
Contact Information
Website
www.newscienceventures.com
Year Founded
2004
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
- 500 West Putnam Avenue
- Suite 400
- Greenwich, CT 06830
- United States
+1 (212) 000-0000
New Science Ventures Investments (119)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Phase Four | 10-Jun-2022 | Later Stage VC | 000.00 | Aerospace and Defense | Generating Revenue | |
| 0000000 | 24-May-2022 | 00000 00000 | 000.00 | Biotechnology | Generating Revenue | 0000-000000 00000 00.0 |
| 0000000 | 15-May-2022 | 00000 00000 | 00.00 | Telecommunications Service Providers | Generating Revenue | |
| 00000000 | 01-Jan-2022 | 00000 00000 | 000.00 | Electronic Equipment and Instruments | Generating Revenue | |
| 00000000 000000000 | 17-Dec-2021 | 00000 00000 | 0000 | Drug Discovery | Clinical Trials - Phase 2 | 000000000000 00000000000 |
| 0000000000 | 06-Dec-2021 | 00000 00000 | 000.00 | Energy Storage | Generating Revenue | 000000000000 00000000000 |
| 000000000 00000000 | 02-Nov-2021 | 00000 00000 | 000.00 | Other Healthcare Technology Systems | Generating Revenue | 000000000000 00000000000 |
| 000 00000 0000000 | 25-Oct-2021 | 00000 00000 | 00000 | Aerospace and Defense | Generating Revenue | |
| Zeotap | 08-Sep-2021 | Later Stage VC | 000.00 | Business/Productivity Software | Generating Revenue | |
| Pakal Tech | 27-Jul-2021 | Early Stage VC | 00.000 | General Purpose Semiconductors | Generating Revenue | 000000000000 00000000000 |
New Science Ventures Exits (43)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Ventyx Biosciences | 21-Oct-2021 | IPO | 00000 |
| 00 000000 | 01-Oct-2021 | 000000000 00000000 | |
| 0000 00000 | 15-Sep-2021 | 000000000 00000000 | |
| 00000000 000000000 | 01-Apr-2021 | 000000000 00000000 | |
| 0000000 0000000000 | 09-Mar-2021 | 000000000000000000 | |
| 0000000 | 26-Jan-2021 | 000000000000000000 | |
| 00000 000000000000 | 27-Aug-2020 | 0000000000 | |
| 000000000 | 03-Apr-2020 | 000000000000000000 | |
| Paradigm Diagnostics | 03-Mar-2020 | Merger/Acquisition | |
| Ario Pharma | 01-Oct-2019 | Out of Business |
New Science Ventures Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
New Science Ventures Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
New Science Ventures Team (11)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Brenda Marex | Chief Financial Officer | New York, NY | |||
| Thomas Lavin | Co-Founder & Partner | 0 | 0 | 0 | New York, NY |
| Jean-Pierre Bizet Ph.D | Partner & Senior Advisor | 0 | 0 | 0 | New York, NY |
| Andrew Abrams | Partner | 0 | 0 | 0 | London, United Kingdom |
| Somasundaram Subramaniam | Co-Founder & Managing Partner | 00 | 0 | 00 | New York, NY |
New Science Ventures Co-Investors (123)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| BioGeneration Ventures | 2 | 0 |
|
|
|
| Forbion | 0 | 0 |
|
|
|
| In-Q-Tel | 0 |
|
|
||
| Société Régionale d'Investissement de Wallonie | 0 | 0 |
|
|
|
| venBio | 0 | 0 |
|
|